Ramipril Mix-Up: Wrong Dose Found in Packets

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a warning concerning specific batches of Ramipril 10mg capsules, manufactured by Crescent Pharma Limited. These batches may erroneously contain blister strips of Ramipril 5mg capsules, a discrepancy identified after a patient discovered the mix-up within a sealed carton.

The error is believed to have occurred during the secondary packaging stage at the manufacturing site. As a precautionary measure, pharmacy and healthcare professionals have been instructed by the MHRA to cease supplying the implicated batch, identified by batch number GR174091, and to return any remaining stock to their suppliers.

Ramipril, a widely used medication for high blood pressure, heart failure, and post-heart attack recovery, helps prevent strokes and kidney problems by aiding blood circulation. The MHRA emphasizes that the risk to patients who may have taken a lower dose for a short period is minimal. While effects from a lower dose are expected to be gradual, individuals experiencing adverse reactions should seek medical advice.

Patients are advised to check their Ramipril 10mg packaging for batch number GR174091. If the carton contains blister strips labeled as Ramipril 5mg, they should contact their dispensing pharmacy. If the blister strips correctly match the 10mg label on the carton, no further action is required.